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I. Materials and Methods 
 
 
Unless noted in the specific procedure, reactions were performed in flame-dried glassware under 
argon atmosphere. All metathesis reactions were carried out under air-free conditions in dry 
glassware in a Vacuum Atmospheres Glovebox filled with N2.  General solvents were purified by 
passing through solvent purification columns.  Commercially available substrates were used as 
received. All solvents and substrates were sparged with Ar before bringing into the glovebox and 
filtered over basic alumina (Brockmann I) prior to use.  Reaction progress was monitored by thin-
layer chromatography (TLC) using E. Merck silica gel 60 F254 precoated plates (0.25 mm) and 
visualized by UV fluorescence quenching, potassium permanganate, or p-anisaldehyde staining.  
Silicycle SiliaFlash P60 Academic Silica gel (particle size 0.040-0.063 mm) was used for flash 
chromatography.  Analytical chiral HPLC was performed with an Agilent 1100 Series HPLC 
utilizing Chiralcel OD-H and OJ-H columns (4.6 mm x 25 cm) obtained from Daicel Chemical 
Industries, Ltd. with visualization at 254 nm.  Analytical SFC was performed with a Mettler SFC 
supercritical CO2 analytical chromatography system utilizing Chiralcel OD-H column (4.6 mm x 
25 cm) obtained from Daicel Chemical Industries, Ltd. with visualization at 210 nm.  GC 
conversion data was obtained using an HP-5 capillary column with an Agilent 6850 FID gas 
chromatograph. 1H and 13C NMR spectra were recorded on a Varian Inova 500 spectrometer (500 
MHz and 126 MHz, respectively), a Bruker AV III HD spectrometer equipped with a Prodigy 
liquid nitrogen temperature cryoprobe (400 MHz and 101 MHz, respectively), or a Varian Mercury 
300 spectrometer (300 MHz and 75 MHz, respectively) and are reported in terms of chemical shift 
relative to residual CHCl3 (δ 7.26 and δ 77.16 ppm, respectively).  Data for 1H NMR spectra are 
reported as follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), integration).  
Abbreviations are used as follows: s = singlet, bs = broad singlet, d = doublet, t = triplet, q = quartet, 
quint = quintet, m = complex multiplet.  Infrared (IR) spectra were recorded on a Perkin Elmer 
Paragon 1000 spectrometer using neat samples on ATR diamond, and are reported in frequency of 
absorption (cm–1).  High-resolution mass spectra HRMS were acquired from the Caltech Mass 
Spectral Facility using fast-atom bombardment (FAB+), electrospray ionization (TOF ES+) or 
electron impact (EI+), and an Agilent 6200 Series TOF with an Agilent G1978A Multimode source 
in electrospray ionization (ESI), atmospheric pressure chemical ionization (APCI), or mixed (MM) 
ionization mode.  Optical rotations were measured on a Jasco P-2000 polarimeter using a 100 mm 
pathlength cell at 589 nm.  
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II. Experimental Procedures and Characterization Data 
 
 
1. Preparation of (±)-6: 
 
 
 
Racemic enone (±)-5 was obtained from photooxygenation of dicyclopentadiene catalyzed by 
tetraphenylporphyrin (TPP) according to Mihelich and Eickhoff’s procedure.1  In a 500 mL round 
bottom flask, (±)-5 (13.2 g, 8.9 mmol) was dissolved in anhydrous toluene (150 mL) under argon 
atmosphere.  The solution was cooled to –78 ºC, and a solution of DIBAL-H (1.0 M solution in 
toluene, 13.4 mL, 13.4 mmol, 1.5 equiv) was added dropwisely.  After 1.5 h, MeOH (50 mL) was 
added (dropwisely at beginning to avoid splashing).  The reaction mixture was warmed to ambient 
temperature, poured into a saturated Na-K tartrate solution (150 mL), and the biphasic solution 
was stirred overnight.  The aqueous phase was extracted with CH2Cl2 (3 × 200 mL).  The combined 
organic phases were dried with anhydrous magnesium sulfate, filtered, and concentrated under 
reduced pressure.  Purification by flash column chromatography on silica gel (SiO2, 10:1 to 4:1 
hexanes/EtOAc) afforded compound (±)-6 as a white solid (10.9 g, 81% yield). 
 
TLC (4:1 hexanes/EtOAc): Rf= 0.3 (KMnO4).  
1H NMR (400 MHz, CDCl3): δ 6.15 (dd, J = 5.7, 2.6 Hz, 1H), 5.81 (dd, J = 5.7, 3.2 Hz, 1H), 5.59 
(s, 2H), 4.67 (t, J = 9.0 Hz, 1H), 3.29 (dd, J = 7.6, 4.1 Hz, 1H), 2.99 – 2.87 (m, 3H), 1.51 (ddt, J = 
46.0, 8.0, 1.6 Hz, 2H), 1.23 (d, J = 9.6 Hz, 1H) 
 
2. Enzymatic kinetic resolution: 
 
 
 
In a 250 mL round bottom flask, (±)-6 (4.8 g, 32.4 mmol) was dissolved in MTBE (100 mL, 0.33 
M), and vinyl acetate (1.78 mL, 19.4 mmol, 0.6 equiv) was added via syringe.  Lipase PS (10% on 
celite, 480 mg, 10 wt%) was added to the flask.  The flask was sealed with a septum and kept under 
argon atmosphere, and placed in 37 ºC oil bath.  After 48 h, the reaction mixture was filtered 
through celite and concentrated.  Column chromatography (SiO2, 10:1 to 4:1 hexanes/EtOAc) 
afforded white solids (–)-7 (2.93 g, 48% yield) and (+)-6 (2.36 g, 49% yield). 
 
DIBAL-H
THF
(81%)(±)-5
O
(±)-6
H
H
OH
lipase PS (10 wt%)
vinyl acetate (0.6 equiv)
MTBE, 37 ºC, 48 h
+
(±)-6 (–)-7 (48%) (+)-6 (49%)
H
H
H
HH
HOH OAc OH
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(–)-7  
 
TLC (10:1 hexanes/EtOAc): Rf= 0.68 (KMnO4).  
1H NMR (400 MHz, CDCl3): δ 5.98 (dd, J = 5.7, 2.9 Hz, 1H), 5.76 (dd, J = 5.6, 3.1 Hz, 1H), 5.70 
(dt, J = 5.8, 2.0 Hz, 1H), 5.55 (dt, J = 5.8, 1.9 Hz, 1H), 5.44 (dq, J = 9.0, 1.7 Hz, 1H), 3.28 (ddt, J 
= 7.6, 3.5, 1.7 Hz, 1H), 3.08 (ddd, J = 8.9, 7.7, 4.1 Hz, 1H), 2.89 (ddp, J = 4.3, 2.9, 1.3 Hz, 1H), 
2.76 (s, 1H), 2.07 (s, 3H), 1.46 (ddt, J = 39.3, 8.2, 1.7 Hz, 2H). 
 
(+)-6  
 
TLC (10:1 hexanes/EtOAc): Rf= 0.28 (KMnO4).  
1H NMR spectrum data matches (±)-6. [𝜶]𝑫𝟐𝟑: +117.9° (c = 1.0, CHCl3). 
 
 
3. Preparation of enone (+)-5: 
 
 
 
To a stirred solution of (–)-7 (2.8 g, 14.7 mmol) in MeOH (50 mL) was added K2CO3 (2.03 g, 14.7 
mmol, 1 equiv).  The solution was stirred for 12 h and was concentrated, then dissolved in water 
(30 mL) and extracted by Et2O (30 mL).  Column chromatography (SiO2, 4:1 hexenes/EtOAc) 
afforded (–)-6 as a white solid (2.04 g, 98%).  Spectrum data matches (±)-6.   [𝜶]𝑫𝟐𝟑: –138.1° (c = 1.0, CHCl3). 
 
A 100 mL round bottom flask containing 4Å molecular sieves (9.0 g) was flame-dried under 
vacuum.  (–)-6 (2.01 g, 13.6 mmol) and NMO (3.19 g, 27.2 mmol, 2 equiv) were added and 
dissolved in MeCN (3 mL) and CH2Cl2 (27 mL).  TPAP (150 mg, 0.42 mmol, 0.03 equiv) was 
then added and the reaction was stirred under argon for 1 hour, and the reaction progress was 
monitored by GC.  The reaction mixture was filtered over celite and concentrated.  Column 
chromatography (SiO2, 4:1 hexenes/EtOAc) afforded (+)-5 as a white solid (1.24 g, 63%).  NMR 
spectrum data matches (±)-5.   
 
TLC (4:1 hexanes/EtOAc): Rf= 0.35 (UV).  
1H NMR (400 MHz, CDCl3): δ 7.38 (dd, J = 5.7, 2.6 Hz, 1H), 5.95 (ddd, J = 7.8, 5.6, 2.3 Hz, 
2H), 5.78 (dd, J = 5.7, 3.0 Hz, 1H), 3.42 (dddd, J = 5.6, 4.2, 2.6, 1.6 Hz, 1H), 3.22 (dt, J = 4.1, 1.8 
Hz, 1H), 2.97 (ddt, J = 4.2, 2.7, 1.4 Hz, 1H), 2.80 (t, J = 5.1 Hz, 1H), 1.68 (dd, J = 54.4, 8.4 Hz, 
2H). 
13C NMR (101 MHz, CDCl3): δ 210.9, 164.7, 137.1, 132.7, 52.9, 50.4, 48.4, 45.1, 44.2. 
(–)-6 (98%)
K2CO3MeOH
(–)-7 (+)-5 (63%, >99% ee)
H
H
O
H
H
H
H
TPAP, NMO
4Å MS
MeCN/CH2Cl2OAc OH
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FTIR (ATR): 2990. 2972, 1683, 1576, 1347, 1333, 1294, 1251, 1224, 1194, 1178, 1120, 1091, 
1018, 959, 853, 817, 784, 739, 721, 652 cm–1.  
HRMS (FAB+, m/z): calc’d for C10H11O [M+H]+ 147.0810, found: 147.0809. [𝜶]𝑫𝟐𝟑: +136.6° (c = 1.0, CHCl3). 
 
 
 
4. Preparation of enone (–)-5: 
 
A. Oxidation with TPAP, NMO 
 
 
A 100 mL round bottom flask containing 4Å molecular sieves (9.0 g) was flame-dried under 
vacuum.  (+)-6 (2.00 g, 13.5 mmol) and NMO (3.16 g, 27 mmol, 2 equiv) were added and dissolved 
in MeCN (3 mL) and CH2Cl2 (27 mL).  TPAP (142 mg, 0.41 mmol, 0.03 equiv) was then added 
and the reaction was stirred under argon for 1 hour, and the reaction progress was monitored by 
GC.  The reaction mixture was filtered over celite and concentrated.  Column chromatography 
(SiO2, 4:1 hexenes/EtOAc) afforded (–)-5 as a white solid (1.41 g, 71%).   
 
B. Oxidation using Stahl’s conditions: 
 
 
An oven-dried, 200 mL round-bottomed flask was charged with alcohol (+)-6  (2.01 g, 13.6 mmol, 
1.0 equiv) and anhydrous MeCN (100 mL).  The solution was vigorously stirred (>700 rpm) open 
to air while being treated with MeObpy (147 mg, 0.68 mmol, 0.05 equiv), Cu(MeCN)4OTf (256 mg, 
0.68 mmol, 0.05 equiv), ABNO (0.04 M in MeCN, 3.4 mL, 135.6 µmol, 0.01 equiv), and then 
NMI (110 µL, 1.36 mmol, 0.10 equiv) via microsyringe.  The resulting brick-red reaction mixture 
was vigorously stirred and exposed to air at ambient temperature until the reaction mixture turned 
blue-green in an hour, at which point TLC analysis indicated the complete consumption of starting 
material.  The reaction mixture was diluted with Et2O (50 mL), and filtered through Celite, washing 
with 50% EtOAc/hexanes.  The filtrate was concentrated in vacuo and the crude residue was 
directly purified by flash chromatography (SiO2, 4:1 hexenes/EtOAc) to afford (–)-5 (1.92 g, 97% 
yield) as a white solid. 
 
(+)-6 (–)-5 (71%, >99% ee)
O
H
HH
H
TPAP, NMO
4Å MS
MeCN/CH2Cl2OH
(+)-6 (–)-5 (97%, >99% ee)
O
H
HH
H
Cu(MeObpy)OTf
(5 mol%)
ABNO (1 mol%)
NMI (10 mol%)
MeCN, air, 23 ºC
OH
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TLC (4:1 hexanes/EtOAc): Rf= 0.35 (UV).  
1H NMR spectrum data matches (+)-5. [𝜶]𝑫𝟐𝟑: –121.9° (c = 1.0, CHCl3). 
 
HPLC Conditions:  
5% IPA, 1.0 mL/min, Chiralcel OJ-H column, λ = 254 nm, tR (min) = 7.78, 8.30 
 
(±)-5: 
 
 
(+)-5: 
 
 
 
(–)-5: 
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5. Preparation of (+)- and (–)-8: 
 
 
 
A 250 mL flask was charged with CuI (2.56 g, 13.44 mmol, 1.2 equiv) and flame-dried under 
vacuum.  After cooling to room temperature, anhydrous THF (100 mL) and Me2S (5 mL) were 
added, and the solution was vigorously stirred for 5 minutes at room temperature until a yellow 
homogeneous solution was formed.  At –78 ºC, allylmagnesium bromide (12.3 mL, 1.0 M solution 
in THF, 12.3 mmol, 1.1 equiv) was added slowly.  The reaction mixture was stirred at –78 ºC for 
1 hour and a solution of (+)-5 (1.637 g, 11.2 mmol, 1.0 equiv) in THF (5 mL) was added slowly. 
After 30 minutes stirring at the same temperature, a solution of trans-2-octenal (2.826 g, 22.4 
mmol, 2.0 equiv) in THF (3 mL) was added slowly.  The reaction was stirred for additional 1 hour 
at –78 ºC, and a solution of saturated NH4Cl and NH3•H2O (100 mL, 9:1 NH4Cl/NH3•H2O) was 
added.  The biphasic solution was warmed to room temperature and was vigorously stirred until a 
homogeneous dark blue solution was formed in the aqueous phase.  The phases were separated 
and the organic phase was washed with 20 mL saturated NH4Cl solution.  The combined aqueous 
phase was extracted with Et2O (3 × 100 mL).  The combined organic phase was dried with 
anhydrous magnesium sulfate, and was concentrated in vacuo. The residue was purified by flash 
chromatography (SiO2, hexanes/EtOAc 15:1) to give a mixture of diastereomers of the aldol 
products (3.6 g). 
 
A portion of the reaction mixture was taken out and the major diastereomer was isolated as follow: 
 
 
 
TLC (4:1 hexanes/EtOAc): Rf= 0.33 (p-anisaldehyde).  
1H NMR (400 MHz, CDCl3): δ 6.18 (dd, J = 5.7, 2.9 Hz, 1H), 6.10 (dd, J = 5.8, 3.0 Hz, 1H), 5.80 
(dddd, J = 15.7, 11.0, 8.1, 6.1 Hz, 1H), 5.63 (dt, J = 15.3, 6.7 Hz, 1H), 5.30 (ddt, J = 15.3, 8.0, 1.6 
Hz, 1H), 5.13 – 5.06 (m, 2H), 4.18 (d, J = 1.9 Hz, 1H), 4.04 (td, J = 8.2, 1.9 Hz, 1H), 3.19 (ddt, J 
= 4.5, 3.0, 1.4 Hz, 1H), 3.09 (ddd, J = 10.2, 4.7, 2.4 Hz, 1H), 2.98 (tt, J = 2.9, 1.6 Hz, 1H), 2.64 
(ddd, J = 9.9, 5.6, 4.1 Hz, 1H), 2.40 (dddd, J = 13.3, 5.5, 3.8, 1.7 Hz, 1H), 2.12 – 1.97 (m, 4H), 
1.57 (dt, J = 8.4, 1.8 Hz, 1H), 1.51 – 1.42 (m, 2H), 1.41 – 1.22 (m, 6H), 0.87 (t, J = 6.9 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 136.3, 135.8, 134.0, 129.8, 117.2, 73.1, 61.8, 56.6, 52.5, 47.2, 
45.9, 45.5, 40.9, 40.4, 32.3, 31.6, 28.8, 22.6, 14.1. (The carbonyl peak was not observed below 
219 ppm) 
1. CuI, Me2S
allylmagnesium bromide
then trans-2-octenal, THF, –78 ºC
2. MsCl, DMAP, CH2Cl2
   –10 ºC to 23 ºC O
Me
(+)-8 (77% yield over 2 steps)
H
H
(+)-5
H
H
O
O
Me
S1
H
H
H
OH
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FTIR (ATR): 3465, 3073, 2957, 2925, 2857, 1709, 1640, 1600, 1439, 1413, 1338, 1249, 1224, 
1090, 973, 911, 836, 733 cm–1.  
HRMS (FAB+, m/z): calc’d for C21H29O2 [M+H–H2]+ 313.2168, found: 313.2158. [𝜶]𝑫𝟐𝟑: +28.1° (c = 1.0, CHCl3). 
 
 
Kobayashi et al. establishes that for compounds S1 (anti-aldols) 3JHa-Hb is in the range of 8.4 to 9.7 
Hz, while for the corresponding syn-aldols 3JHa-Hb is around 3 Hz.2  The stereochemistry of Hb was 
also confirmed by nOe analysis of S1.  
 
 
Without further separation, the crude aldol product was dissolved in CH2Cl2 (200 mL) and cooled 
to 0 ºC.  DMAP (20.5 g, 168 mmol, 15.0 equiv) and MsCl (2.6 mL, 33.6 mmol, 3.0 equiv) were 
added sequentially.  The reaction mixture was slowly warmed to room temperature and was stirred 
for 16 h before washed with 1 M HCl (100 mL).  The aqueous phase was extracted with EtOAc (3 
× 100 mL).  The combined organic phase was dried with anhydrous magnesium sulfate, and was 
concentrated in vacuo.  The residue was purified by flash chromatography (hexanes/EtOAc 20:1) 
to give (+)-8 (2.55 g, 77% yield over 2 steps) as a yellow liquid. 
 
 
 
TLC (10:1 hexanes/EtOAc): Rf= 0.48 (UV).  
1H NMR (400 MHz, CDCl3): δ 6.70 (dd, J = 10.7, 2.1 Hz, 1H), 6.20 – 6.04 (m, 2H), 5.97 (qd, J 
= 5.6, 2.7 Hz, 2H), 5.79 (ddt, J = 17.1, 10.2, 6.9 Hz, 1H), 5.14 – 5.05 (m, 2H), 3.24 (tq, J = 2.8, 
1.4 Hz, 1H), 3.01 (dp, J = 4.4, 1.4 Hz, 1H), 2.97 (dd, J = 8.6, 4.8 Hz, 1H), 2.64 – 2.56 (m, 2H), 
2.35 – 2.26 (m, 1H), 2.22 – 2.07 (m, 3H), 1.49 – 1.37 (m, 4H), 1.35 – 1.23 (m, 4H), 0.89 (t, J = 
6.8 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 209.8, 146.8, 141.1, 136.1, 136.0, 133.5, 132.7, 126.3, 117.1, 
54.0, 51.5, 47.4, 47.2, 43.7, 41.2, 40.3, 33.5, 31.4, 28.5, 22.5, 14.0. 
FTIR (ATR): 3062, 2957, 2928, 2858, 1701, 1625, 1600, 1438, 1341, 1293, 1202, 1178, 1122, 
973, 912, 727, 698 cm–1.  
HRMS (FAB+, m/z): calc’d for C21H29O [M+H]+ 297.2218, found: 297.2214. [𝜶]𝑫𝟐𝟑: +150.4° (c = 1.0, CHCl3). 
 
 
H
H
H
HO OH
H
nOe
Me
O
Me
S1
H
H
Ha OHHb
3JHa-Hb
= 8.2 Hz
O
Me
(+)-8
H
H
Li, Stoltz, and Grubbs  Supporting Information 
 
 S10 
 
 
 
A 250 mL flask was charged with CuI (571 mg, 3 mmol, 1.2 equiv) and flame-dried under vacuum.  
After cooling to room temperature, anhydrous THF (25 mL) and Me2S (1 mL) were added, and 
the solution was vigorously stirred for 5 minutes at room temperature until a yellow homogeneous 
solution was formed.  At –78 ºC, allylmagnesium bromide (2.75 mL, 1.0 M solution in THF, 2.75 
mmol, 1.1 equiv) was added slowly.  The reaction mixture was stirred at –78 ºC for 1 hour and a 
solution of (–)-5 (365 mg, 2.5 mmol, 1.0 equiv) in THF (2 mL) was added slowly.  After 30 minutes 
stirring at the same temperature, a solution of trans-2-octenal (631 mg, 5.0 mmol, 2.0 equiv) in 
THF (1 mL) was added slowly.  The reaction was stirred for additional 1 hour at –78 ºC, and a 
solution of saturated NH4Cl and NH3•H2O (25 mL, 9:1 NH4Cl/NH3•H2O) was added.  The biphasic 
solution was warmed to room temperature and was vigorously stirred until a homogeneous dark 
blue solution was formed in the aqueous phase.  The phases were separated and the organic phase 
was washed with 10 mL saturated NH4Cl solution.  The combined aqueous phase was extracted 
with Et2O (3 × 30 mL).  The combined organic phase was dried with anhydrous magnesium sulfate, 
and was concentrated in vacuo. The residue was purified by flash chromatography (SiO2, 
hexanes/EtOAc 15:1) to give a mixture of diastereomers of the aldol products (790 mg). 
 
Without further separation, the crude aldol product was dissolved in CH2Cl2 (40 mL) and cooled 
to 0 ºC.  DMAP (4.58 g, 37.5 mmol, 15.0 equiv) and MsCl (0.58 mL, 7.5 mmol, 3.0 equiv) were 
added sequentially.  The reaction mixture was slowly warmed to room temperature and was stirred 
for 16 h before washed with 1 M HCl (40 mL).  The aqueous phase was extracted with EtOAc (3 
× 40 mL).  The combined organic phase was dried with anhydrous magnesium sulfate, and was 
concentrated in vacuo.  The residue was purified by flash chromatography (hexanes/EtOAc 20:1) 
to give (–)-8 (559 mg, 75% yield over 2 steps) as a yellow liquid. 
 
Characterization data matches (+)-8. [𝜶]𝑫𝟐𝟑: –193.4° (c = 1.0, CHCl3). 
 
 
 
6. Preparation of (+)- and (–)-9: 
 
 
O
H
H
1. CuI, Me2S
allylmagnesium bromide
then trans-2-octenal, THF, –78 ºC
2. MsCl, DMAP, CH2Cl2
   –10 ºC to 23 ºC O
Me
(–)-8 (75% yield over 2 steps)
H
H
(–)-5
Maleic anhydride
EtAlCl2
DCE
80 ºC, 2 h O
Me
(+)-9 (60%, >99% ee)
O
Me
(+)-8
H
H
Li, Stoltz, and Grubbs  Supporting Information 
 
 S11 
In a 100 mL round bottom flask, (+)-8 (1.64 g, 5.54 mmol, 1.0 equiv) was dissolved in DCE (50 
mL).  Maleic anhydride (5.4 g, 55.4 mmol, 10.0 equiv) and EtAlCl2 (6.0 mL, 1.0 M solution in 
hexanes, 6.0 mmol, 1.1 equiv) were added sequentially.  A reflux condenser was attached and the 
reaction mixture was warmed to reflux under argon.  After 2 hours, the reaction mixture was cooled 
down, concentrated and directly loaded on silica gel.  Purification by flash chromatography 
(hexanes/EtOAc 15:1) afforded (+)-9 (760 mg, 60% yield, >99% ee by chiral HPLC analysis) as 
a colorless liquid. 
 
Spectral data (1H NMR, 13C NMR, HRMS, IR) matched with the published data.3 
TLC (4:1 hexanes/EtOAc): Rf= 0.56 (UV).  
1H NMR (300 MHz, CDCl3): δ 7.50 (ddd, J = 6.0, 2.6, 1.0 Hz, 1H), 6.95 (dt, J = 10.7, 1.2 Hz, 
1H), 6.35 (dd, J = 6.0, 1.8 Hz, 1H), 6.33 – 6.15 (m, 2H), 5.81 – 5.64 (m, 1H), 5.11 – 5.01 (m, 2H), 
3.60 (ddq, J = 8.5, 4.1, 1.9 Hz, 1H), 2.73 – 2.58 (m, 1H), 2.24 (dddd, J = 13.4, 9.7, 6.8, 1.5 Hz, 
3H), 1.54 – 1.37 (m, 2H), 1.38 – 1.22 (m, 4H), 0.96 – 0.84 (t, J = 6.9 Hz, 3H). 
13C NMR (75 MHz, CDCl3): δ 197.5, 160.6, 147.1, 135.4, 134.9, 134.3, 131.8, 125.7, 117.8, 43.2, 
37.4, 33.6, 31.5, 28.6, 22.6, 14.1. 
FTIR (ATR): 2956, 2926, 2856, 1692, 1631, 1580, 1440, 1338, 1280, 1207, 1102, 977, 915, 871, 
839, 801, 753, 730, 666 cm–1.  
HRMS (FAB+, m/z): calc’d for C16H21O [M+H–H2]+ 229.1586, found: 229.1581. [𝜶]𝑫𝟐𝟑: +150.4° (c = 1.0, CHCl3). 
 
 
 
 
In a 50 mL round bottom flask, (–)-8 (667 mg, 2.25 mmol, 1.0 equiv) was dissolved in DCE (20 
mL).  Maleic anhydride (2.2 g, 22.5 mmol, 10.0 equiv) and EtAlCl2 (2.5 mL, 1.0 M solution in 
hexanes, 2.5 mmol, 1.1 equiv) were added sequentially.  A reflux condenser was attached and the 
reaction mixture was warmed to reflux under argon.  After 2 hours, the reaction mixture was cooled 
down, concentrated and directly loaded on silica gel.  Purification by flash chromatography 
(hexanes/EtOAc 15:1) afforded (–)-9 (361 mg, 70% yield, >99% ee by chiral HPLC analysis) as 
a colorless liquid. 
 
Characterization data matches (+)-9. [𝜶]𝑫𝟐𝟑: –122.9° (c = 1.0, CHCl3). 
 
HPLC Conditions:  
5% IPA, 1.0 mL/min, Chiralcel OD-H column, λ = 254 nm, tR (min) = 5.94, 8.23 
 
 
O
Me
(–)-9 (70%, >99% ee)
O
Me
(–)-8
H
H
Maleic anhydride
EtAlCl2
DCE
80 ºC, 2 h
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(±)-9: 
 
 
(+)-9: 
 
 
(–)-9: 
 
 
 
7. Preparation of 10: 
A. One-pot homodimerization/stereoretentive metathesis method: 
 
 
O
Me
cis-5-octen-1-ol
Ru-1 (1 mol %)
   toluene, 23 ºC, 2 torr
then (+)-9, Ru-1 (5 mol %)
THF, 40 ºC, 16 h
(+)-9
O
Me
OH
10 (99% yield, >99:1 Z/E, >99% ee)
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In a nitrogen-filled glovebox, cis-5-octen-1-ol (205 mg, 1.6 mmol, 8.0 equiv) was dissolved in 
toluene (2 mL) in a 50 mL Schlenk flask and a solution of catalyst Ru-1 (13.5 mg, 16 µmol, 1 
mol%) in THF (0.8 mL) was added.  The Schlenk flask was sealed and brought out of the glovebox, 
and then connected to high vacuum.  The valve was gradually opened (Caution: open slowly and 
stir well to avoid splashing).  After 15 minutes stirring, the flask was refilled with argon and sealed, 
and was brought back into the glovebox.  The residue was diluted with THF (0.5 mL), and an 
aliquot was taken for GC analysis (conversion of the homodimerization step was >98% by GC 
analysis).  A solution of (+)-9 (46 mg, 0.2 mmol, 1.0 equiv) in THF (0.5 mL) was added into the 
Schlenk flask and an additional portion of catalyst Ru-1 (8.5 mg, 10 µmol, 5 mol%) solution in 
THF (0.5 mL) was added.  The Schlenk flask was sealed and brought out of glovebox.  The reaction 
was stirred for 16 h at 40 ºC before being quenched with a few drops of ethyl vinyl ether.  The 
solvent was removed under reduced pressure. The residue was purified by flash chromatography 
(hexanes/EtOAc 2:1) to give 10 (60 mg, 99%, >99:1 Z/E, >99% ee by chiral HPLC analysis).   
 
Spectral data (1H NMR, 13C NMR, HRMS, IR) matched with the published data.3 
TLC (4:1 hexanes/EtOAc): Rf= 0.2 (UV).  
1H NMR (400 MHz, CDCl3): δ 7.48 (ddd, J = 6.0, 2.6, 1.0 Hz, 1H), 6.95 (dt, J = 11.0, 1.3 Hz, 
1H), 6.34 – 6.19 (m, 3H), 5.52 – 5.44 (m, 1H), 5.38 – 5.30 (m, 1H), 3.63 (t, J = 6.5 Hz, 2H), 3.60 
– 3.55 (m, 1H), 2.60 (dddd, J = 14.0, 6.2, 4.3, 1.4 Hz, 1H), 2.30 (dtd, J = 14.4, 8.6, 1.2 Hz, 1H), 
2.25 – 2.17 (m, 2H), 2.01 (qd, J = 7.3, 1.4 Hz, 2H), 1.59 – 1.49 (m, 3H), 1.48 – 1.37 (m, 4H), 
1.34 – 1.29 (m, 4H), 0.89 (t, J = 7.0 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 197.6, 160.9, 147.0, 135.4, 135.3, 132.6, 131.8, 125.8, 125.3, 
62.9, 43.7, 33.6, 32.5, 31.5, 30.9, 28.6, 27.2, 25.8, 22.6, 14.2. 
FTIR (ATR): 3445, 2960, 2930, 2862, 1690, 1629, 1580, 1447, 1264, 1207, 1054, 979, 732 cm–
1.  
HRMS (TOF, ES+, m/z): calc’d for C20H31O2 [M+H]+ 303.2319, found: 303.2320. [𝜶]𝑫𝟐𝟑: +142.6° (c = 0.5, CHCl3). 
 
HPLC Conditions: 10% IPA, 1.0 mL/min, Chiralcel OD-H column, λ = 210 nm, tR (min): major = 
9.64, minor = 13.83 
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B. Stereoretentive cross-metathesis method: 
 
 
 
In a nitrogen-filled glovebox, (+)-9 (49 mg, 0.21 mmol, 1.0 equiv) and cis-5-octen-1-ol (205 mg, 
1.6 mmol, 7.6 equiv) were dissolved in THF (0.5 mL) in a 1-dram vial, and the solution was 
transferred to a 50 mL Schlenk flask.  A solution of catalyst Ru-1 (8.5 mg, 10 µmol, 5 mol%) in 
THF (0.5 mL) was added.  The Schlenk flask was sealed and brought out of the glovebox, and 
freeze-pump-thaw for one time to keep it under static vacuum.  The reaction was stirred for 16 h 
at 40 ºC before being quenched with a few drops of ethyl vinyl ether.  The solvent was removed 
under reduced pressure.  The residue was purified by flash chromatography (hexanes/EtOAc 10:1 
to 2:1) to give 10 (30 mg, 47%, >99:1 Z/E) and 11 (29 mg, 53%, >99:1 Z/E) as two major products.   
 
 
 
TLC (4:1 hexanes/EtOAc): Rf= 0.6 (UV).  
1H NMR (400 MHz, CDCl3): δ 7.48 (ddd, J = 5.9, 2.6, 1.0 Hz, 1H), 6.95 (dt, J = 11.2, 1.2 Hz, 
1H), 6.39 – 6.17 (m, 3H), 5.53 – 5.43 (m, 1H), 5.34 – 5.24 (m, 1H), 3.56 (ddq, J = 8.6, 4.1, 2.0 Hz, 
1H), 2.70 – 2.47 (m, 1H), 2.34 – 2.17 (m, 3H), 1.99 (pd, J = 7.5, 1.6 Hz, 2H), 1.46 (p, J = 7.3 Hz, 
2H), 1.31 (tt, J = 5.6, 2.8 Hz, 4H), 0.93 (t, J = 7.6 Hz, 3H), 0.89 (t, J = 6.9 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 197.6, 160.9, 146.8, 135.4, 134.6, 131.7, 125.8, 124.3, 43.8, 33.6, 
31.5, 30.8, 28.6, 22.6, 20.8, 14.3, 14.1. 
FTIR (ATR): 2959, 2927, 2856, 2360, 1693, 1632, 1579, 1459, 1376, 1337, 1294, 1203, 1100, 
1069, 1020, 976, 923, 867, 834, 805, 728, 668 cm–1.  
HRMS (ESI, m/z): calc’d for C18H27O [M+H]+ 259.2056, found: 259.2207. [𝜶]𝑫𝟐𝟑: +210.8° (c = 1.0, CHCl3). 
O
Me
cis-5-octen-1-ol
Ru-1 (5 mol %)
   
THF, 40 ºC, 24 h
static vacuum
(+)-9
O
Me
OH
10 (47% yield, >99:1 Z/E)
+
O
Me
Me
11 (53% yield, >99:1 Z/E)
O
Me
Me
11
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8. Preparation of 15-deoxy-∆12,14-prostaglandin J2 (2): 
 
 
 
Pyridinium chlorochromate (129 mg, 0.6 mmol, 3.0 equiv) was added to a solution of 10 (60 mg, 
0.2 mmol, 1.0 equiv) in CH2Cl2 (2 mL) at room temperature.  The reaction progress was monitored 
by TLC.  The reaction mixture was diluted with Et2O (2 mL) after stirring for 1 h.  The resulting 
solution was filtered through a short pad of celite, concentrated, and subjected to the next step 
without further purification. 
 
The residue was dissolved in t-BuOH (3 mL) at room temperature, 2-methyl-2-butene (210 μL, 
2.0 mmol, 10 equiv), a solution of NaH2PO4•H2O (41.4 mg, 0.3 mmol, 1.5 equiv) in H2O (0.72 
mL), and a solution of NaClO2 (80 %, 33.6 mg, 0.3 mmol, 1.5 equiv) in H2O (0.72 mL) were added 
sequentially.  After stirring at room temperature for 30 minutes, the reaction mixture was diluted 
with a solution of NaH2PO4•H2O (648 mg) in H2O (12 mL) and was extracted with EtOAc (5 × 10 
mL). The combined organic extracts were dried over anhydrous magnesium sulfate, filtered, and 
concentrated under reduced pressure.  Flash column chromatography (SiO2, CH2Cl2/MeOH 20:1) 
afforded pure compound 2 (41.0 mg, 65% yield over 2 steps) as a colorless oil.  
 
Spectral data (1H NMR, 13C NMR, HRMS, IR) matched with the published data.3 
TLC (100% EtOAc): Rf= 0.70 (UV). 
1H NMR (400 MHz, CDCl3): δ 7.47 (dd, J = 6.0, 2.5 Hz, 1H), 6.95 (d, J = 11.0 Hz, 1H), 6.38 – 
6.19 (m, 3H), 5.50 – 5.33 (m, 2H), 3.62 – 3.55 (m, 1H), 2.63 – 2.55 (m, 1H), 2.38 – 2.26 (m, 3H), 
2.23 (q, J = 7.1 Hz, 2H), 2.05 (q, J = 7.3 Hz, 2H), 1.68 (p, J = 7.4 Hz, 2H), 1.46 (p, J = 7.1 Hz, 
2H), 1.37 – 1.25 (m, 4H), 0.90 (t, J = 6.9 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 197.6, 177.9, 160.8, 147.2, 135.5, 135.1, 131.9, 131.5, 126.2, 
125.8, 43.6, 33.6, 33.2, 31.6, 30.8, 28.6, 26.7, 24.6, 22.6, 14.2. 
FTIR (ATR): 2960, 2928, 2850, 1708, 1692, 1629, 1456, 1265, 1207, 978, 734, 703 cm–1.  
HRMS (TOF, ES+, m/z): calc’d for C20H29O3 [M+H]+ 317.2111, found: 317.2127. [𝜶]𝑫𝟐𝟑: +154.4° (c = 1.0, CHCl3). 
 
9. Preparation of 15-deoxy-∆12,14-prostaglandin J2 methyl ester (15): 
 
 
 
O
Me
OH
1. PCC, CH2Cl2
2. NaClO2, NaH2PO4•H2O
2-methyl-2-butene
t-BuOH, H2O
O
Me
COOH
10 15d-PGJ2 (2)
(65% yield over 2 steps)
O
Me
COOH
15d-PGJ2 (2)
TMSCHN2
benzene/MeOH
23 ºC, 2 h O
Me
COOMe
15 (72% yield, >99% ee)
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In a 1-dram vial, 15d-PGJ2 (2) (8.0 mg, 25 µmol, 1.0 equiv) was dissolved in C6H6/MeOH (3:2, 
0.75 mL) at 23 °C.  A solution of trimethylsilyldiazomethane (20 µL, 2.0 M in hexanes, 40 µmol, 
1.5 equiv) (yellow color persists).  After stirring for 2 hours, the reaction mixture was concentrated 
under vacuum.  The residue was purified by flash column chromatography (SiO2, hexanes/EtOAc, 
4:1) to give 15 (6.0 mg, 72% yield, >99% ee) as a colorless oil. 
 
TLC (4:1 hexanes/EtOAc): Rf= 0.28 (UV).  
1H NMR (400 MHz, CDCl3): δ 7.47 (ddd, J = 6.0, 2.6, 1.0 Hz, 1H), 6.95 (dt, J = 11.0, 1.2 Hz, 
1H), 6.37 – 6.17 (m, 3H), 5.50 – 5.31 (m, 2H), 3.66 (s, 3H), 3.57 (ddt, J = 8.7, 3.8, 2.0 Hz, 1H), 
2.64 – 2.56 (m, 1H), 2.33 – 2.18 (m, 5H), 2.03 (q, J = 7.3 Hz, 2H), 1.66 (p, J = 7.5 Hz, 2H), 1.46 
(p, J = 7.2 Hz, 2H), 1.31 (ddt, J = 9.3, 5.3, 3.6 Hz, 4H), 0.89 (t, J = 6.9 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 197.5, 174.0, 160.8, 147.1, 135.5, 135.2, 131.8, 131.6, 126.1, 
125.8, 51.7, 43.6, 33.6, 33.5, 31.6, 30.9, 28.6, 26.8, 24.8, 22.6, 14.1. 
FTIR (ATR): 2953, 2927, 2856, 2360, 2342, 1736, 1694, 1632, 1579, 1436, 1364, 1205, 1090, 
979, 836, 729, 668 cm–1.  
HRMS (ESI, m/z): calc’d for C21H31O3 [M+H]+ 331.2268, found: 331.2720. [𝜶]𝑫𝟐𝟑: +72.1° (c = 0.2, CHCl3). 
 
SFC Conditions:  
10% IPA, 4.0 mL/min, Chiralcel OD-H column, λ = 254 nm, tR (min)= 6.27, 7.09 
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 1H–1H COSY NMR (400 MHz, CDCl3) of compound S1. 
  
1H–13C HSQC NMR (400 MHz, CDCl3) of compound S1. 
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NOESY NMR (400 MHz, CDCl3) of compound 68. 
  NOESY
 NMR (400 MHz, CDCl3) of compound 68. 
  
1H–13C HMBC NMR (400 MHz, CDCl3) of compound S1. 
  
NOESY NMR (400 MHz, CDCl3) of compound S1. 
  
